Simvastatin tablets
Closed Solicitation Posted
- Solicitation number
- SPE2DP27T0193
- Agency
-
Medical Supply Chain
Troop Support, Department of Defense
- Responses due
- Set-aside
- No set-aside
Opportunity facts
- NAICS code
- Not on record
- PSC
- 6505 Drugs And Biologicals
- More information
Notice details come from SAM.gov. Updated .
About this opportunity
The Defense Logistics Agency Troop Support Medical is soliciting quotations for Simvastatin Tablets, NSN 6505-01-354-4544, 5 BT, with quotes due November 3, 2026. The procurement carries no set-aside (No Set-Aside Used), but the RFQ lists two acceptable manufacturers: PURACAP LABORATORIES LLC (CAGE 4JB85, NDC 24658-0501-90) and AUROLIFE PHARMA LLC (CAGE 7ZU31, NDC 52343-0022-90).
Solicitation SPE2DP27T0193 is a Fast Auto Evaluation request for quotation issued by DLA office SPE2DP. Quotes must be submitted through DIBBS. The RFQ states the acquisition has potential for automated award and may qualify for Fast Pay if the final award value falls below the simplified acquisition threshold. Terms are FOB Destination with inspection at destination, and delivery is required within 20 days.
Per the attached RFQ summary, delivery is to Flugplatz Spangdahlem, Germany, for 10 MG, 90-count bottles. The item is FDA-regulated and requires packaging and marking compliance with MIL-STD-2073-1E and Medical Marking Standard No. 1. The shelf life requirement is 36 months, non-extendable, under TYPE I coding. The solicitation incorporates the DLA Master Solicitation for Automated Simplified Acquisitions (Revision 105, May 20, 2026) and the DLA Technical and Quality Master List. Included clauses cover hazardous material identification, sea transport of supplies, cybersecurity safeguarding, small business program representations, and covered defense telecommunications equipment restrictions.
The notice states no award value or ceiling. The attached summary reports prior awards for this item between 2018 and 2025 ranging from $4.95 to $12.99 per unit.
Notice text
DLA request for quotation SPE2DP27T0193, issued by DLA office SPE2DP through DIBBS. Quotes are due by 11/03/2026. Set-aside: No Set-Aside Used. Solicitation type: Fast Auto Evaluation. FOB Destination. Inspection at Destination. Item: line 0001, SIMVASTATIN TABLETS, NSN 6505-01-354-4544, 5 BT, delivery in 20 days, PR 7018857651. Quotes must be submitted via DIBBS.
Files
| File | Type | Posted |
|---|---|---|
| SPE2DP27T0193.pdf |
Similar open opportunities
| Opportunity | Agency | Set-aside | Responses due |
|---|---|---|---|
| Citalopram hydrobromi | Medical Supply Chain | No set-aside | |
| Fluconazole tablets | Medical Supply Chain | No set-aside | |
| Isoniazid tablets | Medical Supply Chain | No set-aside | |
| ANALYZER,BLOOD CHOLES and 1 more item | Medical Supply Chain | No set-aside | |
| Docusate sodium capsu | Medical Supply Chain | No set-aside |
On GovTribe
Work this opportunity
- Track it in your pipeline
- Find teaming partners
- Similar opportunities
- Ask GovTribe AI about this opportunity